95253 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
ISOINDOLIN-1-ONE DERIVATIVES USEFUL AS GRK2 INHIBITORS
#1202Anti-viral compounds
#1203PIPERAZINYL AND PIPERIDINYL QUINAZOLIN-4(3H)-ONE DERIVATIVES HAVING ACTIVITY AGAINST PAIN
#1204HISTONE ACETYLTRANSFERASE (HAT) INHIBITOR AND USE THEREOF
#1205ENZYME INHIBITORS
#12063,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof
#1207Cereblon binding compounds, compositions thereof, and methods of treatment therewith
#1208Heterocyclic inhibitors of PCSK9
#1209Tetrazole derivatives as TRPA1 inhibitors
#1210Compounds for the treatment of respiratory diseases
#1211RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
#1212Inhibitors of cyclin dependent kinase 7 (CDK7)
#1213QUINAZOLINYL-INDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#1214Compound and organic light emitting device comprising the same
#1215Organic molecules for optoelectronic devices
#1216INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#1217Indazole compound or salt thereof
#1218Compound and organic electroluminescence device
#1219Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof
#1220EGFR inhibitor compounds
#1221INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#1222Cyclic compound and organic light emitting device comprising same
#1223Bicyclic aza compounds as muscarinic Mand/or Mreceptor agonists
#1224SUBSTITUTED PHENYLPROPENYL PYRIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL APPLICATIONS
#1225Processes of preparing a JAK1 inhibitor
#1226Compounds
#1227PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#1228INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#1229AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCER
#1230SMAC mimetics used as IAP inhibitors and use thereof
#1231MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN
#1232Compound and organic light emitting device comprising the same
#1233Heterocyclic compound
#1234ORGANIC LIGHT-EMITTING ELEMENT
#1235Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device
#1236COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME
#1237HETEROCYCLIC COMPOUNDS EXHIBITING THERMALLY ACTIVATED DELAYED FLUORESCENCE (TADF) AND THEIR USE IN ELECTROLUMINESCENT DEVICES
#1238Compound and organic light emitting device comprising the same
#1239Modulators of THR-β and methods of use thereof
#1240Inhibitors of cysteine proteases and methods of use thereof
#1241THYROID HORMONE RECEPTOR AGONISTS
#1242REGULATOR OF NITROGEN-CONTAINING HETEROAROMATIC DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF
#1243Use of AURKB small-molecule inhibitors for treatment of non-small cell lung cancer
#1244BIARYL PIPERIDINE AMIDE COMPOUNDS AND METHODS OF USE THEREOF
#1245Carbocyclic prolinamide derivatives
#1246INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
#1247Inhibitors of EGFR and methods of use thereof
#1248CD73 inhibitors
#1249Inhibiting agents for Bruton's tyrosine kinase
#1250Triazine based radiopharmaceuticals and radioimaging agents
#1251Imaging Agents
#1252GLP-1 receptor agonists and uses thereof
#1253Benzonitrile derivative, light-emitting material, and light-emitting element using same
#1254Multi-aziridine compound
#1255Isoindolin-1-on derivative, method for preparing same, and pharmaceutical composition comprising same as effective component for preventing or treating cancer
#1256Electron buffering material and organic electroluminescent device comprising the same
#1257Nitric oxide releasing phosphodiesterase type 5 inhibitor
#1258METALLOENZYME INHIBITOR COMPOUNDS
#1259Organic molecules for optoelectronic devices
#1260Diamine compound, polyimide precursor using same, and polyimide film
#1261NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS
#1262Phenoxytriazoles
#1263Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
#12645-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
#1265NLRX1 ligands
#1266Electroluminescent devices
#1267PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS
#1268Compounds and compositions for inhibiting the activity of SHP2
#1269Substituted pyrimidines as LRKK2 inhibitors
#1270Pyrazole derivatives as H4 antagonist compounds
#1271Inhibitors of RAF kinases
#1272OGA INHIBITOR COMPOUNDS
#1273Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
#1274Substituted phenazines and methods of treating cancer and bacterial diseases
#1275Cyclic Ureas
#1276Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
#1277HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS
#1278Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma
#1279COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT
#1280METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE
#1281INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#1282Substituted indole Mcl-1 inhibitors
#1283Substituted pyrimidine compounds as multifunctional radical quenchers and their uses
#1284Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
#1285Methods for treating Huntington's disease
#1286Pharmaceutical compounds
#1287Organic electroluminescence device and compound for organic electroluminescence device
#1288Compound for organic electric element, organic electric element using the same, and electronic device thereof
#1289ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS
#1290Pyrimidine derivative and preparation process and use thereof
#12911,2,4-triazole derivatives as tankyrase inhibitors
#12922,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES
#12931,5-disubstituted 1,2,3-triazoles are inhibitors of Rac/Cdc42 GTPases
#1294ERK inhibitor and use thereof
#1295PYRIMIDINE OR PYRIDINE COMPOUNDS, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USES THEREOF
#1296Modulators of RAS GTPase
#1297Nitrogen-heterocyclic compound, display panel and display apparatus
#1298METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C
#1299Compound For Organic Electronic Element, Organic Electronic Element Using Same, And Electronic Device Thereof
#1300PYRROLIDINE AMINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
#1301Pyrrolidine compounds
#1302Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof
#1303SUBSTITUTED 2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME
#1304INDOLIN-2-ONE OR PYRROLO -PYRIDIN -2 -ONE DERIVATIVES
#1305Triazine Compounds and Uses Thereof
#1306METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE
#1307Bipyrazole derivatives as JAK inhibitors
#1308SMALL MOLECULE IRE1-ALPHA INHIBITORS
#1309SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS
#1310Compounds and Their Use for Reducing Uric Acid Levels
#1311Spirocyclic tetrahydroquinazolines
#1312Cyclohexyl acid triazole azines as LPA antagonists
#1313ASYMMETRIC TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME
#1314Antibacterial compounds
#1315ORGANIC ELECTROLUMINESCENT ELEMENT
#1316Compound for organic electric element, organic electric element using the same, and electronic device thereof
#1317HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING
#1318Pyrimidine derivative, method for preparing same and use thereof in medicine
#1319Antibacterial compounds
#1320PYRAZOLE DERIVATIVES AS SGC STIMULATORS
#1321Materials for organic electroluminescent devices
#1322Materials for organic electroluminescent devices
#1323sGC STIMULATORS
#1324Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders
#1325Inhibitors of human immunodeficiency virus replication
#1326JAK3 selective inhibitor
#1327Amide compounds and method for making and using
#13281,3-dipolar cycloadditions, and Staudinger ligations for conjugating biomolecules using click chemistry
#1329NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF
#1330Benzimidazole compounds as agricultural chemicals
#1331AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS
#1332SMYD INHIBITORS
#1333COMPOUNDS AND METHODS FOR CD73 MODULATION AND INDICATIONS THEREFOR
#1334Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
#13353-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
#1336Analgesic drug using PAC1 receptor antagonistic drug
#1337ATM kinase inhibitors and compositions and methods of use thereof
#1338JAK1 selective inhibitors
#1339Antagonists of the muscarinic acetylcholine receptor M4
#1340Organic molecules for use in optoelectronic devices
#1341Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
#1342Heterocyclic compound, organic light emitting diode comprising same, composition for organic layer of organic light emitting diode, and method for manufacturing organic light emitting diode
#1343Heteroaryl inhibitors of PAD4
#1344Proteasome activity enhancing compounds
#1345Substituted benzimidazoles as inhibitors of transforming growth factor-β kinase
#1346Organic molecules for use in organic devices
#1347Compound, composition including the same, liquid composition, and organic electroluminescent device
#1348Material for forming organic film, method for forming organic film, patterning process, and compound
#1349Water soluble novel cyanine fluorophore with tunable properties between near IR and SWIR region for in vivo imaging
#1350NEW COMPOUNDS FOR USE AS A THERAPEUTICALLY ACTIVE SUBSTANCE AND IN PARTICULAR FOR USE IN THE TREATMENT OF TUMORS
#1351Substituted triazole derivatives and uses thereof
#1352PRIMARY CARBOXAMIDES AS BTK INHIBITORS
#1353Organic molecules for use in organic optoelectronic devices
#1354Methods and compositions for modulating splicing
#1355Matrix metalloproteinase (MMP) inhibitors and methods of use thereof
#1356Process for Manufacturing Pibrentasvir Active Drug Substance
#1357Methods and composition of 4-substituted benzoylpiperazine-1-substituted carbonyls as beta-catenin/B-cell lymphoma 9 inhibitors
#1358Tropomyosin-related kinase (TRK) inhibitors
#1359Cyclohexyl acid triazole azoles as LPA antagonists
#1360EP4 antagonist
#1361Peripherally-restricted dual-acting kappa and delta opioid agonist for analgesia in pain states involving the inflammatory response
#1362Tryptophan hydroxylase inhibitor and pharmaceutical composition including same
#1363Pyrazolylacylpyrazoline compounds and method for treating pain
#1364Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides
#1365LIGHT-EMITTING ELEMENT, AND DISPLAY, ILLUMINATOR, AND SENSOR EACH INCLUDING SAME
#1366Pyrrolidinyl urea derivatives and application thereof in TrkA-related diseases
#1367Pyrrolotriazine compounds as TAM inhibitors
#1368SUBSTITUTED PYRROLIDINES AS FACTOR XIA INHIBITORS FOR THE TREATMENT THROMBOEMBOLIC DISEASES
#1369DIFLUOROMETHYL-PHENYL TRIAZOLES
#1370RHO KINASE INHIBITORS
#1371Imidazolyl kinase inhibitors and uses thereof
#1372Pyrrolidine and piperidine compounds
#1373Benzimidazolone derived inhibitors of BCL6
#1374Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same
#1375Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1- yl)pyrimidin-4-amine and new salts
#1376MODULATORS OF CELLULAR ADHESION
#1377PIKfyve inhibitors
#1378Heterocyclic RIP1 inhibitory compounds
#1379Heterocyclic amides useful as protein modulators
#1380Ferroportin inhibitors
#1381Prodigiosin Analogs And Methods Of Use
#1382Pyrimidine derivative containing one deuterium atom and preparation process and use thereof
#1383(HETERO)ARYL SULFONAMIDE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISMS
#1384COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES
#1385Organic compound and organic electroluminescent device using the same
#1386Compositions and methods for inhibiting kinases
#1387Pyridazinones as PARP7 inhibtors
#1388Inhibitors of cyclin-dependent kinases
#1389Heparanase inhibitors and use thereof
#1390Pyridazinone compounds and uses thereof
#1391Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases
#1392Tetramaleimide linkers and use thereof
#1393Heterocyclic carboxylate compounds as glycolate oxidase inhibitors
#1394Bicyclic heterocycle compounds and their uses in therapy
#1395GLS1 inhibitors for treating disease
#1396Amino compounds for treatment of immune and inflammatory disorders
#1397Amide compounds for treatment of immune and inflammatory disorders
#1398KDM1A inhibitors for the treatment of disease
#1399Thyroid hormone receptor agonists and uses thereof
#1400MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#1401Protease-activated contrast agents for in vivo imaging
#1402BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF
#1403Compounds and pharmaceutical compositions thereof for the treatment of diseases
#1404Histone acetyltransferase (HAT) inhibitor and use thereof
#1405Substituted benzenecarboxamides as IL-17A modulators
#1406ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME
#1407Fluorine-substituted indazole compounds and uses thereof
#1408PYRIMIDINE COMPOUND, PREPARATION METHOD THEREOF AND MEDICAL USE THEREOF
#1409Azolopyrimidine for the treatment of cancer-related disorders
#1410Compound, display panel, and display apparatus
#1411Compound, organic electroluminescent device and display equipment
#1412Organic electroluminescent element, electronic device, and compound
#1413Bicyclic heterocycles as FGFR inhibitors
#1414Carboxamide compounds and uses thereof
#1415Inhibitors of receptor interacting protein kinase I for the treatment of disease
#1416INHIBITORS OF EGFR AND METHODS OF USE THEREOF
#1417Arylamide compounds and compositions and uses thereof
#1418Diazole lactams
#1419Substituted cyanoindoline derivatives as NIK inhibitors
#1420Modulators of STING (stimulator of interferon genes)
#1421COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE
#1422Cyclohexyl acid pyrazole azines as LPA antagonists
#1423FACTOR XIIa INHIBITORS
#1424ASK1 INHIBITOR COMPOUNDS AND USES THEREOF
#1425Irreversible covalent organic framework for efficient and selective gold recovery and preparation method thereof
#1426INHIBITORS FOR THE B-CATENIN/B-CELL LYMPHOMA 9 (BCL9) PROTEIN-PROTEIN INTERACTION
#1427Cyclohexyl acid pyrazole azoles as LPA antagonists
#1428Compounds and methods for inhibiting JAK
#1429Benzoimidazoles as prolyl hydroxylase inhibitors
#1430Pyrimidines as EGFR inhibitors and methods of treating disorders
#1431HIV protease inhibitors
#1432Therapeutic compounds and methods of use thereof
#14332-substituted pyrazole amino-4-substituted amino-5-pyrimidine formamide compound, composition, and application thereof
#1434ORGANIC ELECTROLUMINESCENCE DEVICE
#1435Compound For Organic Electronic Element, Organic Electronic Element Using Same, And Electronic Device Thereof
#1436Apelin receptor (APJ) agonists and uses thereof
#1437HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
#1438Heterocyclic RIP1 kinase inhibitors
#1439RIP1 inhibitory compounds and methods for making and using the same
#14402-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
#1441RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
#1442DNA-PK inhibitors
#1443Organic electroluminescent materials and devices
#1444Enhancement of nucleic acid polymerization by aromatic compounds
#14457-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the same
#1446Reactive oxygen species scavengers and use for treating diseases
#14475-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
#14482-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof
#1449Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof
#1450Inhibitors of the menin-MLL interaction
#1451Pyrazole MAGL inhibitors
#1452PD-1/PD-L1 inhibitors
#1453Acryloyl-containing nuclear transport regulators and uses thereof
#1454Tetrahydroisoquinoline derivatives, preparation process and use thereof
#1455Organic compound, and organic light emitting diode and organic light emitting display device including the same
#1456HETEROCYCLIC COMPOUNDS EXHIBITING THERMALLY ACTIVATED DELAYED FLUORESCENCE (TADF) AND THEIR USE IN ELECTROLUMINESCENT DEVICES
#1457Bromodomain Inhibitors
#1458Hetero ring-fused phenyl compounds for inhibiting TNIK and medical uses thereof
#1459Lanthionine synthetase C-like 2-based therapeutics
#1460Hole transporting material, method for preparing same, and electroluminescent device
#1461Inhibitors of EGFR and methods of use thereof
#1462Indole derivatives as estrogen receptor degraders
#1463Solid forms of an HPK1 inhibitor
#1464Pyrazine-2(1H)-ketone compound acting as FGFR inhibitor
#1465Pharmaceutical compounds
#1466NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME
#1467Modulators of Rho-associated protein kinase
#1468Sting agonist compounds and methods of use
#1469Cyanoindoline derivatives as NIK inhibitors
#14703-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
#1471Pyrazol-3-ones that activate pro-apoptotic BAX
#1472Organic electroluminescent materials and devices
#1473Heteroaryl[4,3-C]pyrimidine-5-amine derivative, preparation method therefor, and medical uses thereof
#1474Five-membered ring-substituted pyridazinol compounds and derivatives, preparation methods, herbicidal compositions and applications thereof
#14754-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication
#1476Pyridazinones as PARP7 inhibitors
#1477Covalent inhibitors of KRAS
#1478BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE
#1479Branched multi-functional macromonomers and related polymers and uses thereof
#1480Small molecule inhibitors of EGFR and PI3K
#1481Compound and organic light-emitting device including the same
#1482Heterocycle-substituted bicyclic azole pesticides
#1483PHARMACOKINETICALLY IMPROVED COMPOUNDS
#1484Inhibitors for the β-catenin / T-cell factor protein-protein interaction
#1485Carbazole-based compound and organic light emitting diode comprising same
#1486Synthetic receptors for ionophoric compounds
#1487Methods and compounds for treating disorders
#1488HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS
#1489Anti-cancer compounds
#1490THERAPEUTIC COMPOUNDS
#1491N4-phenyl-quinazoline-4 -amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
#1492Organic molecules for optoelectronic devices
#1493COMPOUND, RESIN, COMPOSITION, AND FILM FORMING MATERIAL FOR LITHOGRAPHY USING THE SAME
#1494Indazole compounds and uses thereof
#1495HETEROARYLPYRIMIDINE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISMS
#1496Compounds, compositions, and methods
#1497PKM2 MODULATORS AND METHODS FOR THEIR USE
#1498Compound and organic light emitting display device
#1499GLS1 inhibitors for treating disease
#1500Compositions and methods for treating infections